-+ 0.00%
-+ 0.00%
-+ 0.00%

Alvotech's AVT80 Biosimilar To Entyvio Passes Key Pharmacokinetic Study, Showing Safety And Immunogenicity Profiles In Healthy Participant

Benzinga·02/05/2026 08:24:28
Listen to the news

The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in healthy adult participants, met all its primary endpoints